Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Psychiatry ; 57(10): 1176-85, 2005 May 15.
Article in English | MEDLINE | ID: mdl-15866558

ABSTRACT

BACKGROUND: This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation. METHODS: Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge. RESULTS: In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation. CONCLUSIONS: This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.


Subject(s)
Maze Learning/physiology , Obsessive-Compulsive Disorder/physiopathology , Obsessive-Compulsive Disorder/psychology , Receptor, Serotonin, 5-HT1D/physiology , Receptor, Serotonin, 5-HT2C/physiology , Animals , Anti-Anxiety Agents/pharmacology , Antidepressive Agents, Tricyclic/pharmacology , Desipramine/pharmacology , Diazepam/pharmacology , Disease Models, Animal , Fluoxetine/pharmacology , Indoles/pharmacology , Male , Piperazines/pharmacology , Piperidines/pharmacology , Rats , Rats, Wistar , Reinforcement, Psychology , Serotonin Receptor Agonists/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Tryptamines
SELECTION OF CITATIONS
SEARCH DETAIL
...